(Total Views: 349)
Posted On: 01/25/2018 6:54:50 PM
Post# of 15624
Many believe this company hypes, I and perhaps others feel just the opposite. If they were really into hype, wouldn't they do the following:
1. Issue a PR each time they initiated, or gained any sort of approval for a patent.
2. Issue a PR when they filed an IND to initiate a trial, another when the IRB approved, and still another when the trial was initiated.
3. Put every trial they're running or intending to run in the clinical trials database and update them as warranted.
4. Conduct a webcast each time they had quarterly or annual results to report.
5. Issue a PR to discuss the preclinical results they've gotten prior to each new drug reached the point of going into clinical trials.
OWCP has done practically none of the above, they've quietly moved drugs into the clinic in Israel and the most they've done is issue a corporate presentation update. This is about as far from hype as a company could go. That's not to say that others don't hype the stock, but those others don't work for the company.
Gary
1. Issue a PR each time they initiated, or gained any sort of approval for a patent.
2. Issue a PR when they filed an IND to initiate a trial, another when the IRB approved, and still another when the trial was initiated.
3. Put every trial they're running or intending to run in the clinical trials database and update them as warranted.
4. Conduct a webcast each time they had quarterly or annual results to report.
5. Issue a PR to discuss the preclinical results they've gotten prior to each new drug reached the point of going into clinical trials.
OWCP has done practically none of the above, they've quietly moved drugs into the clinic in Israel and the most they've done is issue a corporate presentation update. This is about as far from hype as a company could go. That's not to say that others don't hype the stock, but those others don't work for the company.
Gary
(1)
(0)
